Evanesc Therapeutics
Evanesc Therapeutics has developed a revolutionary medical device, EvaPermea, that uses low power RF electric fields to non-invasively and temporarily open the blood-brain barrier to allow existing or new drugs to be used in the treatment of various neurological disorders and Central Nervous System (CNS) diseases. The device has applications in the treatment of Alzheimer's and Parkinson's disease, as well as brain cancer and brain metastases.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Evanesc Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Evanesc Therapeutics
1 distinct titles indexed · top 1 shown.
- 1chief technology officer, co-founder
Sign up to unlock all 1 contacts at Evanesc Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Evanesc Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.